Evidence map›Paper›PMID 26074775›Full record

ReviewFrontiers in cellular neuroscience2015

Neuronal epigenetics and the aging synapse.

Jorge Azpurua, Benjamin A Eaton

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. The Potential Role of miRNAs in Cognitive Frailty.Frontiers in aging neuroscience · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Long noncoding RNA GM12371 acts as a transcriptional regulator of synapse function.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jorge AzpuruaDepartment of Physiology, University of Texas Health Science Center at San Antonio San Antonio, TX, USA.
Benjamin A EatonDepartment of Physiology, University of Texas Health Science Center at San Antonio San Antonio, TX, USA.
The University of Texas Health Science Center at San Antonio · US

Funding

Regulation of synaptic proteasome activity by the dynactin complexR01NS062811 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI EATON, BENJAMIN ARTHUR · 2010 to 2014
$1.6M
Cellular Mechanisms of Chemotherapy-Induced Peripheral NeuropathyR21CA194138 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI EATON, BENJAMIN ARTHUR, HARGREAVES, KENNETH M · 2015 to 2016
$363k
NCI NIH HHS R21 CA194138NINDS NIH HHS R01 NS062811
6 · The paper itself

Abstract

Two of the most salient phenotypes of aging are cognitive decline and loss of motor function, both of which are controlled by the nervous system. Cognition and muscle contraction require that neuronal synapses develop and maintain proper structure and function. We review the literature on how normal physiological aging disrupts central and peripheral synapse function including the degradation of structure and/or control of neurotransmission. Here we also attempt to connect the work done on the epigenetics of aging to the growing literature of how epigenetic mechanisms control synapse structure and function. Lastly, we address possible roles of epigenetic mechanisms to explain why the basal rates of age-related dysfunction vary so widely across individuals.

Indexed as

acetylationagingepigeneticsneurotransmissionsynapses

Identifiers

PMID26074775
PMCPMC4444820
OpenAlexW1538735195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.